Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8R5K

The Fk1 domain of FKBP51 in complex with Antascomicine B

Summary for 8R5K
Entry DOI10.2210/pdb8r5k/pdb
DescriptorPeptidyl-prolyl cis-trans isomerase FKBP5, Antascomicine B (3 entities in total)
Functional Keywordsisomerase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight14701.93
Authors
Voll, M.A.,Bracher, A.,Hausch, F. (deposition date: 2023-11-16, release date: 2024-05-08)
Primary citationSchafer, S.C.,Voll, A.M.,Bracher, A.,Ley, S.V.,Hausch, F.
Antascomicin B stabilizes FKBP51-Akt1 complexes as a molecular glue.
Bioorg.Med.Chem.Lett., 104:129728-129728, 2024
Cited by
PubMed Abstract: Antascomicin B is a natural product that similarly to the macrolides FK506 and Rapamycin binds to the FK506-binding protein 12 (FKBP12). FK506 and Rapamycin act as molecular glues by inducing ternary complexes between FKBPs and additional target proteins. Whether Antascomicin B can induce ternary complexes is unknown. Here we show that Antascomicin B binds tightly to larger human FKBP homologs. The cocrystal structure of FKBP51 in complex with Antascomicin B revealed that large parts of Antascomicin B are solvent-exposed and available to engage additional proteins. Cellular studies demonstrated that Antascomicin B enhances the interaction between human FKBP51 and human Akt. Our studies show that molecules with molecular glue-like properties are more prominent in nature than previously thought. We predict the existence of additional 'orphan' molecular glues that evolved to induce ternary protein complexes but where the relevant ternary complex partners are unknown.
PubMed: 38582133
DOI: 10.1016/j.bmcl.2024.129728
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (0.89 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon